Authors

CHENG GENG1, XINJIAN XU2, XIAOHAN NIE3, DU LU4, JIANGANG LI5, QILONG CHEN6, YISIMAYILI ISIMAYILI·AIMAITI7, TUERXUNJIANG TUXUN8, XIYAN WANG9

Departments

1Department of Panctreatic Surgery, Digestive and Vascular Center, 1st Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China - 2Department of Panctreatic Surgery, Digestive and Vascular Center, 1st Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China - 3Department of Panctreatic Surgery, Digestive and Vascular Center, 1st Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China - 4Tumor Hospital of Xinjiang Medical University, Urumqi 830054, China - 5Department of General Surgery, 2rd Affiliated Hospital of Xinjiang Medical University, Urumqi China - 6Department of Panctreatic Surgery, Digestive and Vascular Center, 1st Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China - 7Department of General Surgery,The first people's Hospital of Kashi District, Xinjiang China - 8Digestive and Vascular Center, 1st Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China - 9Tumor Hospital of Xinjiang Medical University, Urumqi 830054, China

Abstract

Purpose: To investigate the expression of HP antibody and the relationship between HP infection and risk factors for pan- creatic cancer.

Methods: A total of 138 patients were recruited over a 1-year period for this study. They were divided into two groups: observation (68 patients with pancreatic cancer) and control (70 healthy patients). The observation group consisted of 37 males and 32 females aged between 29 and 67 years (mean age = 55.73 ± 5.67 years), while the control group consisted of 38 males and 32 females aged between 24 and 65 years (mean age = 54.26 ± 5.17 years). Pancreatic cancer was established using surgery, pathological and clinical diagnoses. Specimens from the patients were subjected to immunohistochemistry and Western blotting to determine the expressions of HP antibody and cytotoxin-associated gene A-HP IgG (Cag A-HP-IgG).

Results: The positive expression of HP antibody in the observation group (69.12 %) was significantly higher (p < 0.05) than that of control (48.47 %). The expression of Cag A-HP IgG in the observation group (40.43 %) was also significantly higher (p < 0.05) than that of control (17.65 %), and HP infection in patients with pancreatic cancer was closely related to smoking and history of chronic pancreatitis, both of which acted synergistically.

Conclusion: Helicobacter pylori contributes to the development of chronic pancreatitis which can ultimately lead to pan- creatic cancer.

Keywords

Pancreatic cancer, Helicobacter pylori, Infection, Antibody, Risk factors

DOI:

10.19193/0393-6384_2019_1_8